Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing iothalamate meglumine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iothalamate meglumine (substance) |
Inferred relationship |
Some |
|
Meglumine iothalamate 60% infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iothalamate meglumine (substance) |
Inferred relationship |
Some |
|
Iothalamate meglumine 172mg/mL injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iothalamate meglumine (substance) |
Inferred relationship |
Some |
|
Iothalamate meglumine 30% injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iothalamate meglumine (substance) |
Inferred relationship |
Some |
|
Iothalamate meglumine 600mg/mL injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iothalamate meglumine (substance) |
Inferred relationship |
Some |
|
Iothalamate meglumine 43% injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iothalamate meglumine (substance) |
Inferred relationship |
Some |
|
Meglumine iothalamate 60% infusion solution 20 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iothalamate meglumine (substance) |
Inferred relationship |
Some |
|
Meglumine iothalamate 60% infusion solution 50 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iothalamate meglumine (substance) |
Inferred relationship |
Some |
|
Iothalamate meglumine 66.8% injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iothalamate meglumine (substance) |
Inferred relationship |
Some |
|